PREVALENCE OF ANTI-CN1A ANTIBODIES AND ITS CLINICAL SIGNIFICANCE - A RETROSPECTIVE MONOCENTRIC STUDY

被引：0
|
作者：
Silva, S. P. [1 ,2 ]
Fortes, C. [2 ,3 ]
Eugenio, G. [1 ,2 ]
Barcelos, A. [1 ,2 ,4 ]
机构：
[1] Ctr Hosp Baixo Vouga, Rheumatol Dept, Aveiro, Portugal
[2] Egas Moniz Hlth Alliance Acad Clin Ctr, Aveiro, Portugal
[3] Ctr Hosp Baixo Vouga, Clin Pathol, Aveiro, Portugal
[4] Nova Med Sch, Comprehens Hlth Res Ctr, Lisbon, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Descriptive studies; Autoantibodies; Epidemiology;
D O I：
10.1136/annrheumdis-2023-eular.5959
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1539
引用
收藏
页码：2002 / 2003
页数：2
相关论文
共 50 条
  • [41] CLINICAL SIGNIFICANCE OF ANTI-INSULIN-ANTIBODIES
    ANDERSEN, OO
    ACTA ENDOCRINOLOGICA, 1976, 83 : 231 - 240
  • [42] Prevalence and clinical significance of IgG isotype anti-beta(2)-glycoprotein I antibodies in antiphospholipid syndrome: A comparative study with anticardiolipin antibodies
    Sanmarco, M
    Soler, C
    Christides, C
    Raoult, D
    Weiller, PJ
    Gerolami, V
    Bernard, D
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 129 (05): : 499 - 506
  • [43] Anti-Ku antibodies. Study of prevalence and of clinical meaning
    Beyne-Rauzy, O
    Couret, B
    Fortenfant, F
    Adoue, D
    REVUE DE MEDECINE INTERNE, 2004, 25 (09): : 619 - 622
  • [44] Prevalence and clinical significance of lymphadenopathy and its histological subtypes in patients with systemic lupus erythematosus: a retrospective cohort study
    Eleni Papachristodoulou
    Elizabeth Graef
    Daniel Magliulo
    Vasileios Kyttaris
    Rheumatology International, 2023, 43 : 1277 - 1286
  • [45] Prevalence and clinical significance of lymphadenopathy and its histological subtypes in patients with systemic lupus erythematosus: a retrospective cohort study
    Papachristodoulou, Eleni
    Graef, Elizabeth
    Magliulo, Daniel
    Kyttaris, Vasileios
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (07) : 1277 - 1286
  • [46] Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis
    Liaskos, C
    Rigopoulou, E
    Zachou, K
    Georgiadou, S
    Gatselis, N
    Papamihali, R
    Dalekos, GN
    JOURNAL OF AUTOIMMUNITY, 2005, 24 (03) : 251 - 260
  • [47] Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis
    Ceribelli, A.
    Fredi, M.
    Taraborelli, M.
    Cavazzana, I.
    Tincani, A.
    Selmi, C.
    Chan, J. Y. F.
    Chan, E. K. L.
    Satoh, M.
    Franceschini, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : 891 - 897
  • [48] Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis
    Avcin, T
    Cimaz, R
    Falcini, F
    Zulian, F
    Martini, G
    Simonini, G
    Porenta-Besic, V
    Cecchini, G
    Borghi, MO
    Meroni, PL
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (07) : 608 - 611
  • [49] The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy
    Zhang, Ya-Mei
    Yang, Han-Bo
    Shi, Jing-Li
    Chen, He
    Shu, Xiao-Ming
    Lu, Xin
    Wang, Guo-Chun
    Peng, Qing-Lin
    CLINICAL RHEUMATOLOGY, 2018, 37 (06) : 1573 - 1580
  • [50] The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy
    Ya-Mei Zhang
    Han-Bo Yang
    Jing-Li Shi
    He Chen
    Xiao-Ming Shu
    Xin Lu
    Guo-Chun Wang
    Qing-Lin Peng
    Clinical Rheumatology, 2018, 37 : 1573 - 1580
12345